Close
ACHEMA MIDDLE EAST 2026

Possible Autoimmune Breakthrough With BCMA CAR T Therapy

It is well to be noted that the positive results from the first global study for chimeric antigen receptor (CAR)-antologous T cell- BCMA CAR...

NHSs BRCA Gene Testing Programme To Ascertain Cancer Risk

The BRCA gene testing initiative looks to identify individuals who carry genetic faults associated with an elevated risk of specific cancers, thereby enabling early...

Prescribe Fluoroquinolone Antibiotics As Last Resort – MHRA

It has been determined that fluoroquinolone antibiotics should only be prescribed in cases where no other antibiotics happen to be appropriate for use, as...

2024 Has A Lot Many Questions In Store For Pharma Companies

The advent of powerful new drugs in the case of obesity has gone on to reshape the pharma sector, thereby transforming Eli Lilly as...

CDMO-Biotech Ties Help Cut Business Risk In Drug Development

Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high...

Cancer Research Boosts Small Molecule CDMO Market Expansion

The projected worth of the Global Small Molecule Innovator CDMO Market is anticipated to surpass $76.50 billion by 2031, displaying a compounded annual growth...

Breakthrough Cell & Gene Therapies To Transform Healthcare

Gene and cell therapies have the potential to revolutionize healthcare by reprogramming the immune system to treat diseases that are difficult to address with...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...